Literature DB >> 2885596

Diagnosis of tuberculous meningitis by detection of tuberculostearic acid in cerebrospinal fluid.

G L French, R Teoh, C Y Chan, M J Humphries, S W Cheung, G O'Mahony.   

Abstract

Tuberculostearic acid, a structural component of Mycobacterium tuberculosis, was identified by gas chromatography/mass spectrometry with selected ion monitoring in cerebrospinal fluid (CSF) from 13 patients with proven and 8 out of 9 patients with suspected tuberculous meningitis; the negative result was in a patient whose symptoms and CSF abnormalities may have been due to systemic lupus erythematosus. Tuberculostearic acid was found in the CSF of only 1 patient out of 87 with non-tuberculous meningitis or non-infectious disorders; the single false-positive result was probably caused by intrathecal treatment with amikacin. Other aminoglycosides and antituberculous drugs did not interfere with the assay. In serial CSF samples from patients with tuberculous meningitis tuberculostearic acid was still present after 8 months of continuous supervised chemotherapy. Detection of tuberculostearic acid in CSF is a rapid, sensitive, and specific test for tuberculous meningitis, and can be used for retrospective diagnosis in patients who have been started on therapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2885596     DOI: 10.1016/s0140-6736(87)92328-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

Review 1.  The cerebrospinal fluid in the diagnosis of tuberculous meningoencephalitis: review of the literature.

Authors:  M Macucci; D Sità
Journal:  Ital J Neurol Sci       Date:  1992-09

2.  Differentiation of sarcoidosis from tuberculosis by use of electron capture gas-liquid chromatography.

Authors:  P L Almenoff; J B Brooks; A Johnson; M Lesser
Journal:  Lung       Date:  1996       Impact factor: 2.584

3.  Direct detection of Mycobacterium tuberculosis in clinical specimens by DNA amplification.

Authors:  D De Wit; L Steyn; S Shoemaker; M Sogin
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

Review 4.  New approaches to the diagnosis of tuberculosis in childhood with special reference to neurotuberculosis.

Authors:  J M Grange
Journal:  Indian J Pediatr       Date:  1990 Sep-Oct       Impact factor: 1.967

5.  Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens.

Authors:  G E Pfyffer; P Kissling; E M Jahn; H M Welscher; M Salfinger; R Weber
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

Review 6.  The new diagnostic mycobacteriology laboratory.

Authors:  M Salfinger; G E Pfyffer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 7.  Diagnosis of tuberculosis: available technologies, limitations, and possibilities.

Authors:  Sanjay K Garg; R P Tiwari; Dileep Tiwari; Rupinder Singh; Dolly Malhotra; V K Ramnani; G B K S Prasad; Ramesh Chandra; M Fraziano; V Colizzi; Prakash S Bisen
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

8.  Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence setting.

Authors:  Vinod B Patel; Ahmed I Bhigjee; Hoosain F Paruk; Ravesh Singh; Richard Meldau; Cathy Connolly; Thumbi Ndung'u; Keertan Dheda
Journal:  Cerebrospinal Fluid Res       Date:  2009-11-02

Review 9.  Central nervous system tuberculosis: pathogenesis and clinical aspects.

Authors:  R Bryan Rock; Michael Olin; Cristina A Baker; Thomas W Molitor; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

10.  Structural basis for the recognition of mycolic acid precursors by KasA, a condensing enzyme and drug target from Mycobacterium tuberculosis.

Authors:  Johannes Schiebel; Kanishk Kapilashrami; Agnes Fekete; Gopal R Bommineni; Christin M Schaefer; Martin J Mueller; Peter J Tonge; Caroline Kisker
Journal:  J Biol Chem       Date:  2013-10-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.